Einträge von Kitko, Carrie L. auf dem Publikationsserver

Etra, Aaron, Capellini, Alexandra, Alousi, Amin, Al Malki, Monzr M., Choe, Hannah, DeFilipp, Zachariah, Hogan, William J., Kitko, Carrie L., Ayuk, Francis, Baez, Janna, Gandhi, Isha, Kasikis, Stelios, Gleich, Sigrun, Hexner, Elizabeth, Hoepting, Matthias, Kapoor, Urvi, Kowalyk, Steven, Kwon, Deukwoo, Langston, Amelia, Mielcarek, Marco, Morales, George, Özbek, Umut, Qayed, Muna, Reshef, Ran, Rösler, Wolf, Spyrou, Nikolaos, Young, Rachel, Chen, Yi-Bin, Ferrara, James L. M. und Levine, John E. (2023) Effective treatment of low-risk acute GVHD with itacitinib monotherapy. Blood 141 (5), S. 481-489. Volltext nicht vorhanden.

Akahoshi, Yu, Spyrou, Nikolaos, Hogan, William J., Ayuk, Francis, DeFilipp, Zachariah, Weber, Daniela, Choe, Hannah K., Hexner, Elizabeth O., Rösler, Wolf, Etra, Aaron M., Sandhu, Karamjeet, Yanik, Gregory A., Chanswangphuwana, Chantiya, Kitko, Carrie L., Reshef, Ran, Kraus, Sabrina, Wölfl, Matthias, Eder, Matthias, Bertrand, Hannah, Qayed, Muna, Merli, Pietro, Grupp, Stephan A., Aguayo-Hiraldo, Paibel, Schechter, Tal, Ullrich, Evelyn, Baez, Janna, Beheshti, Rahnuma, Gleich, Sigrun, Kowalyk, Steven, Morales, George, Young, Rachel, Kwon, Deukwoo, Nakamura, Ryotaro, Levine, John E., Ferrara, James L. M. und Chen, Yi-Bin (2023) Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD. Blood Advances 7 (16), S. 4479-4491. Volltext nicht vorhanden.

Al Malki, Monzr M., London, Kaitlyn, Baez, Janna, Akahoshi, Yu , Hogan, William J. , Etra, Aaron, Choe, Hannah, Hexner, Elizabeth , Langston, Amelia , Abhyankar, Sunil, Ponce, Doris M., DeFilipp, Zachariah, Kitko, Carrie L., Adekola, Kehinde, Reshef, Ran, Ayuk, Francis, Capellini, Alexandra, Chanswangphuwana, Chantiya, Eder, Matthias, Eng, Gilbert, Gandhi, Isha, Grupp, Stephan, Gleich, Sigrun, Holler, Ernst, Javorniczky, Nora Rebeka, Kasikis, Stelios, Kowalyk, Steven, Morales, George, Özbek, Umut, Rösler, Wolf, Spyrou, Nikolaos, Yanik, Gregory, Young, Rachel, Chen, Yi-Bin, Nakamura, Ryotaro, Ferrara, James L. M. und Levine, John E. (2023) Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease. Blood Advances 7 (17), S. 5189-5198. Volltext nicht vorhanden.

Etra, Aaron, Gergoudis, Stephanie, Morales, George, Spyrou, Nikolaos, Shah, Jay , Kowalyk, Steven, Ayuk, Francis, Baez, Janna, Chanswangphuwana, Chantiya, Chen, Yi-Bin, Choe, Hannah, DeFilipp, Zachariah, Gandhi, Isha, Hexner, Elizabeth, Hogan, William J., Holler, Ernst, Kapoor, Urvi, Kitko, Carrie L., Kraus, Sabrina, Lin, Jung-Yi, Al Malki, Monzr, Merli, Pietro , Pawarode, Attaphol, Pulsipher, Michael A., Qayed, Muna, Reshef, Ran, Rösler, Wolf, Schechter, Tal, Van Hyfte, Grace, Weber, Daniela, Wölfl, Matthias, Young, Rachel, Özbek, Umut, Ferrara, James L. M. und Levine, John E. (2022) Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification. Blood Advances 6 (12), S. 3707-3715. Volltext nicht vorhanden.

Zewde, Makda Getachew, Morales, George, Gandhi, Isha, Özbek, Umut, Aguayo-Hiraldo, Paibel, Ayuk, Francis, Baez, Janna, Chanswangphuwana, Chantiya, Choe, Hannah, DeFilipp, Zachariah, Etra, Aaron, Grupp, Stephan, Hexner, Elizabeth O., Hogan, William, Javorniczky, Nora Rebeka, Kasikis, Stelios, Kitko, Carrie L., Kowalyk, Steven, Meedt, Elisabeth, Merli, Pietro, Nakamura, Ryotaro, Qayed, Muna, Reshef, Ran, Rösler, Wolf, Schechter, Tal, Weber, Daniela, Wölfl, Matthias, Yanik, Gregory, Young, Rachel, Levine, John E., Ferrara, James L. M. und Chen, Yi-Bin (2021) Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease. Transplantation and Cellular Therapy 27 (12), 988.e1-988.e7. Volltext nicht vorhanden.

DeFilipp, Zachariah, Couriel, Daniel R., Lazaryan, Aleksandr, Bhatt, Vijaya Raj, Buxbaum, Nataliya P. , Alousi, Amin M., Olivieri, Attilio, Pulanic, Drazen, Halter, Joerg P., Henderson, Lori A., Zeiser, Robert , Gooley, Ted A., MacDonald, Kelli P.A. , Wolff, Daniel, Schultz, Kirk R., Paczesny, Sophie, Inamoto, Yoshihiro, Cutler, Corey S., Kitko, Carrie L., Pidala, Joseph A., Lee, Stephanie J., Socie, Gerard, Sarantopoulos, Stefanie, Pavletic, Steven Z., Martin, Paul J., Blazar, Bruce R. und Greinix, Hildegard T. (2021) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report. Transplantation and Cellular Therapy 27 (9), S. 729-737. Volltext nicht vorhanden.

Kitko, Carrie L., Pidala, Joseph, Schoemans, Hélène M., Lawitschka, Anita, Flowers, Mary E., Cowen, Edward W., Tkaczyk, Eric , Farhadfar, Nosha, Jain, Sandeep, Steven, Philipp, Luo, Zhonghui K., Ogawa, Yoko , Stern, Michael, Yanik, Greg A., Cuvelier, Geoffrey D.E., Cheng, Guang-Shing, Holtan, Shernan G., Schultz, Kirk R., Martin, Paul J., Lee, Stephanie J., Pavletic, Steven Z., Wolff, Daniel, Paczesny, Sophie, Blazar, Bruce R., Sarantopoulos, Stephanie, Socie, Gerard, Greinix, Hildegard und Cutler, Corey (2021) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report. Transplantation and Cellular Therapy 27 (7), S. 545-557. Volltext nicht vorhanden.

Wolff, Daniel, Radojcic, Vedran, Lafyatis, Robert, Cinar, Resat, Rosenstein, Rachel K., Cowen, Edward W., Cheng, Guang-Shing, Sheshadri, Ajay, Bergeron, Anne, Williams, Kirsten M., Todd, Jamie L., Teshima, Takanori, Cuvelier, Geoffrey D.E., Holler, Ernst, McCurdy, Shannon R., Jenq, Robert R., Hanash, Alan M., Jacobsohn, David, Santomasso, Bianca D., Jain, Sandeep, Ogawa, Yoko, Steven, Philipp, Luo, Zhonghui Katie, Dietrich-Ntoukas, Tina, Saban, Daniel, Bilic, Ervina, Penack, Olaf, Griffith, Linda M., Cowden, Meredith, Martin, Paul J., Greinix, Hildegard T., Sarantopoulos, Stefanie, Socie, Gerard, Blazar, Bruce R., Pidala, Joseph, Kitko, Carrie L., Couriel, Daniel R., Cutler, Corey, Schultz, Kirk R., Pavletic, Steven Z., Lee, Stephanie J. und Paczesny, Sophie (2021) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report. Transplantation and Cellular Therapy 27 (10), S. 817-835. Volltext nicht vorhanden.

Gergoudis, Stephanie C., DeFilipp, Zachariah, Özbek, Umut, Sandhu, Karamjeet S., Etra, Aaron M., Choe, Hannah K., Kitko, Carrie L., Ayuk, Francis, Aziz, Mina, Baez, Janna, Ben-David, Kaitlyn, Bunworasate, Udomsak, Gandhi, Isha, Hexner, Elizabeth O., Hogan, William J., Holler, Ernst, Kasikis, Stelios, Kowalyk, Steven M., Lin, Jung-Yi, Merli, Pietro, Morales, George, Nakamura, Ryotaro, Reshef, Ran, Rösler, Wolf, Srinagesh, Hrishikesh, Young, Rachel, Chen, Yi-Bin, Ferrara, James L. M. und Levine, John E. (2020) Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin. Blood Advances 4 (24), S. 6098-6105. Volltext nicht vorhanden.

Aziz, Mina D., Shah, Jay, Kapoor, Urvi, Dimopoulos, Christina, Anand, Sarah, Augustine, Allan, Ayuk, Francis, Chaudhry, Mohammed, Chen, Yi-Bin, Choe, Hannah K., Etra, Aaron, Gergoudis, Stephanie, Hartwell, Matthew J. , Hexner, Elizabeth O., Hogan, William J., Kitko, Carrie L., Kowalyk, Steven, Kröger, Nicolaus, Merli, Pietro , Morales, George, Nakamura, Ryotaro, Ordemann, Rainer, Pulsipher, Michael A., Qayed, Muna, Reshef, Ran , Rösler, Wolf, Schechter, Tal, Schreiner, Elisabeth, Srinagesh, Hrishikesh, Wölfl, Matthias, Wudhikarn, Kitsada, Yanik, Gregory, Young, Rachel, Özbek, Umut, Ferrara, James L. M. und Levine, John E. (2020) Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant. Leukemia 34 (7), S. 1898-1906. Volltext nicht vorhanden.

Srinagesh, Hrishikesh K., Özbek, Umut, Kapoor, Urvi, Ayuk, Francis, Aziz, Mina, Ben-David, Kaitlyn, Choe, Hannah K., DeFilipp, Zachariah, Etra, Aaron, Grupp, Stephan A., Hartwell, Matthew J. , Hexner, Elizabeth O. , Hogan, William J., Karol, Alexander B., Kasikis, Stelios, Kitko, Carrie L., Kowalyk, Steven, Lin, Jung-Yi, Major-Monfried, Hannah, Mielke, Stephan, Merli, Pietro, Morales, George, Ordemann, Rainer, Pulsipher, Michael A., Qayed, Muna, Reddy, Pavan, Reshef, Ran, Rösler, Wolf, Sandhu, Karamjeet S., Schechter, Tal, Shah, Jay, Sigel, Keith, Weber, Daniela, Wölfl, Matthias, Wudhikarn, Kitsada, Young, Rachel, Levine, John E. und Ferrara, James L. M. (2019) The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease. Blood Advances 3 (23), S. 4034-4042. Volltext nicht vorhanden.

Major-Monfried, Hannah, Renteria, Anne S., Pawarode, Attaphol, Reddy, Pavan, Ayuk, Francis, Holler, Ernst, Efebera, Yvonne A., Hogan, William J., Wölfl, Matthias, Qayed, Muna, Hexner, Elizabeth O., Wudhikarn, Kitsada, Ordemann, Rainer, Young, Rachel, Shah, Jay, Hartwell, Matthew J. , Chaudhry, Mohammed S., Aziz, Mina, Etra, Aaron, Yanik, Gregory A., Kröger, Nicolaus, Weber, Daniela, Chen, Yi-Bin, Nakamura, Ryotaro, Rösler, Wolf, Kitko, Carrie L., Harris, Andrew C., Pulsipher, Michael, Reshef, Ran, Kowalyk, Steven, Morales, George, Torres, Ivan, Özbek, Umut, Ferrara, James L. M. und Levine, John E. (2018) MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD. Blood 131 (25), S. 2846-2855. Volltext nicht vorhanden.

Jagasia, Madan H., Greinix, Hildegard T., Arora, Mukta, Williams, Kirsten M., Wolff, Daniel, Cowen, Edward W., Palmer, Jeanne, Weisdorf, Daniel, Treister, Nathaniel S., Cheng, Guang-Shing, Kerr, Holly, Stratton, Pamela, Duarte, Rafael F., McDonald, George B., Inamoto, Yoshihiro, Vigorito, Afonso, Arai, Sally, Datiles, Manuel B. , Jacobsohn, David, Heller, Theo, Kitko, Carrie L., Mitchell, Sandra A., Martin, Paul J., Shulman, Howard, Wu, Roy S., Cutler, Corey S., Vogelsang, Georgia B., Lee, Stephanie J., Pavletic, Steven Z. und Flowers, Mary E.D. (2015) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report. Biology of Blood and Marrow Transplantation 21 (3), 389-401.e1. Volltext nicht vorhanden.